nevirapine has been researched along with Depression in 4 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
Excerpt | Relevance | Reference |
---|---|---|
" No baseline differences in depression or suicidal ideation were found between patients ever exposed to efavirenz and those never exposed to efavirenz and receiving nevirapine (P > 0." | 7.88 | Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study. ( Bangsberg, DR; Boum, Y; Bwana, M; Chang, JL; Haberer, JE; Hunt, PW; Martin, JN; Musinguzi, N; Muzoora, C; Siedner, MJ; Tsai, AC, 2018) |
" This study utilized Bayesian logistic regression to examine maternal-level predictors of adherence to infant nevirapine prophylaxis, including intimate partner violence, maternal adherence, HIV serostatus disclosure reaction, recency of HIV diagnosis, and depression." | 3.88 | A Bayesian Analysis of Prenatal Maternal Factors Predicting Nonadherence to Infant HIV Medication in South Africa. ( Cook, RR; Jones, DL; Peltzer, K; Rodriguez, VJ; Weiss, SM, 2018) |
" No baseline differences in depression or suicidal ideation were found between patients ever exposed to efavirenz and those never exposed to efavirenz and receiving nevirapine (P > 0." | 3.88 | Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study. ( Bangsberg, DR; Boum, Y; Bwana, M; Chang, JL; Haberer, JE; Hunt, PW; Martin, JN; Musinguzi, N; Muzoora, C; Siedner, MJ; Tsai, AC, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cook, RR | 1 |
Peltzer, K | 1 |
Weiss, SM | 1 |
Rodriguez, VJ | 1 |
Jones, DL | 1 |
Chang, JL | 1 |
Tsai, AC | 1 |
Musinguzi, N | 1 |
Haberer, JE | 1 |
Boum, Y | 1 |
Muzoora, C | 1 |
Bwana, M | 1 |
Martin, JN | 1 |
Hunt, PW | 1 |
Bangsberg, DR | 1 |
Siedner, MJ | 1 |
Mwesigire, DM | 1 |
Wu, AW | 1 |
Martin, F | 1 |
Katamba, A | 1 |
Seeley, J | 1 |
Potard, V | 1 |
Chassany, O | 1 |
Lavignon, M | 1 |
Costagliola, D | 1 |
Spire, B | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Novel Approaches to Monitoring and Utilizing Adherence to HIV Therapy in Uganda[NCT01596322] | 750 participants (Actual) | Observational | 2004-09-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 other studies available for nevirapine and Depression
Article | Year |
---|---|
A Bayesian Analysis of Prenatal Maternal Factors Predicting Nonadherence to Infant HIV Medication in South Africa.
Topics: Adolescent; Adult; Anti-HIV Agents; Bayes Theorem; Depression; Depression, Postpartum; Disclosure; F | 2018 |
Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Depression; Female; HIV Infections; Hu | 2018 |
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Depression; Fema | 2015 |
Better health-related quality of life after switching from a virologically effective regimen to a regimen containing efavirenz or nevirapine.
Topics: Adult; Aged; Alkynes; Anxiety; Benzoxazines; Cyclopropanes; Depression; Female; France; Health Statu | 2010 |